Bridger Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.4M | Hold |
101,893
| – | – | 5% | 5 |
|
|
2025
Q4 | $6.76M | Buy |
101,893
+59,893
| +143% | +$3.87M | 4.35% | 8 |
|
|
2025
Q3 | $2.83M | Buy |
+42,000
| New | +$3.32M | 1.52% | 24 |
|
|
2024
Q3 | – | Sell |
-28,900
| Closed | -$3.28M | – | 30 |
|
|
2024
Q2 | $3.28M | Hold |
28,900
| – | – | 1.69% | 16 |
|
|
2024
Q1 | $4.01M | Buy |
+28,900
| New | +$3.63M | 1.81% | 18 |
|
|
2023
Q4 | – | Sell |
-38,800
| Closed | -$3.62M | – | 36 |
|
|
2023
Q3 | $3.62M | Buy |
+38,800
| New | +$4.37M | 1.33% | 23 |
|
|
2022
Q1 | – | Sell |
-10,708
| Closed | -$1.44M | – | 54 |
|
|
2021
Q4 | $1.44M | Sell |
10,708
-20,704
| -66% | -$2.98M | 0.19% | 40 |
|
|
2021
Q3 | $4.29M | Sell |
31,412
-56,400
| -64% | -$7.11M | 0.5% | 37 |
|
|
2021
Q2 | $9.37M | Buy |
87,812
+20,188
| +30% | +$1.94M | 0.87% | 34 |
|
|
2021
Q1 | $6.08M | Sell |
67,624
-36,872
| -35% | -$3.46M | 0.57% | 40 |
|
|
2020
Q4 | $9.66M | Sell |
104,496
-20,612
| -16% | -$1.84M | 0.74% | 32 |
|
|
2020
Q3 | $12.9M | Sell |
125,108
-26,532
| -17% | -$2.77M | 1.03% | 29 |
|
|
2020
Q2 | $15.4M | Buy |
151,640
+58,908
| +64% | +$5.27M | 1.42% | 26 |
|
|
2020
Q1 | $6.24M | Sell |
92,732
-50,468
| -35% | -$3.14M | 0.72% | 31 |
|
|
2019
Q4 | $7.83M | Sell |
143,200
-239,504
| -63% | -$11.4M | 0.56% | 34 |
|
|
2019
Q3 | $14.3M | Sell |
382,704
-76,724
| -17% | -$2.98M | 1.18% | 27 |
|
|
2019
Q2 | $17.2M | Buy |
459,428
+254,220
| +124% | +$7.99M | 1.35% | 26 |
|
|
2019
Q1 | $6.11M | Sell |
205,208
-20,620
| -9% | -$725K | 0.48% | 33 |
|
|
2018
Q4 | $6.76M | Sell |
225,828
-1,371,088
| -86% | -$43.5M | 0.56% | 34 |
|
|
2018
Q3 | $57.1M | Sell |
1,596,916
-1,087,104
| -41% | -$33.7M | 3.3% | 15 |
|
|
2018
Q2 | $63.7M | Sell |
2,684,020
-906,460
| -25% | -$19.2M | 3.45% | 11 |
|
|
2018
Q1 | $66.6M | Buy |
3,590,480
+187,380
| +6% | +$2.77M | 4.04% | 9 |
|
|
2017
Q4 | $48.8M | Buy |
+3,403,100
| New | +$44.2M | 3.22% | 14 |
|
|
2017
Q2 | – | Sell |
-1,538,892
| Closed | -$32.6M | – | 40 |
|
|
2017
Q1 | $32.6M | Buy |
+1,538,892
| New | +$30M | 1.86% | 29 |
|
|
2016
Q4 | – | Sell |
-2,155,436
| Closed | -$47.2M | – | 41 |
|
|
2016
Q3 | $47.2M | Sell |
2,155,436
-678,144
| -24% | -$15.1M | 3.18% | 14 |
|
|
2016
Q2 | $56.2M | Sell |
2,833,580
-503,232
| -15% | -$8.57M | 3.63% | 10 |
|
|
2016
Q1 | $56.7M | Buy |
3,336,812
+2,220,652
| +199% | +$37.1M | 3.92% | 9 |
|
|
2015
Q4 | $22.9M | Buy |
+1,116,160
| New | +$23.2M | 0.76% | 25 |
|
Other funds holding DXCM
VCM
VPM
Bridger Management's DXCM Position: Q1 2026 in Review
Bridger Management held its DexCom (DXCM) position steady in Q1 2026 at 101,893 shares worth $6.4M. The position accounts for 5% of the portfolio, ranked #5.
Bridger Management first reported a position in DXCM in Q4 2015 and has held it in 28 quarters since. The position peaked at $66.6M in Q1 2018. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Bridger Management held 101,893 shares of DexCom worth $6.4M as of Q1 2026.
- Bridger Management left its DexCom share count unchanged in Q1 2026.
- DexCom made up 5% of Bridger Management's portfolio in Q1 2026, its #5 holding.
- Bridger Management first reported a position in DexCom in Q4 2015 and has held it in 28 quarters since.
- Bridger Management's DexCom position peaked at $66.6M in Q1 2018.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Bridger Management's 13F filing for Q1 2026, filed 15 May 2026.